RMTI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RMTI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Rockwell Medical's cash to debt ratio for the quarter that ended in Sep. 2024 was 1.29.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Rockwell Medical could pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.
The historical rank and industry rank for Rockwell Medical's Cash-to-Debt or its related term are showing as below:
During the past 13 years, Rockwell Medical's highest Cash to Debt Ratio was No Debt. The lowest was 0.38. And the median was 6.59.
The historical data trend for Rockwell Medical's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Rockwell Medical Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Cash-to-Debt | Get a 7-Day Free Trial |
![]() |
![]() |
6.45 | 2.45 | 0.78 | 1.31 | 0.81 |
Rockwell Medical Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Cash-to-Debt | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
0.79 | 0.81 | 0.61 | 0.83 | 1.29 |
For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Rockwell Medical's Cash-to-Debt falls into.
This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.
Rockwell Medical's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:
Cash to Debt Ratio | = | Cash, Cash Equivalents, Marketable Securities | / | Total Debt | ||
= | Cash, Cash Equivalents, Marketable Securities | / | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | |
= | 10.935 | / | (2.183 | + | 11.256) | |
= | 0.81 |
Rockwell Medical's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:
Cash to Debt Ratio | = | Cash, Cash Equivalents, Marketable Securities | / | Total Debt | ||
= | Cash, Cash Equivalents, Marketable Securities | / | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | |
= | 18.272 | / | (2.61 | + | 11.566) | |
= | 1.29 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rockwell Medical (NAS:RMTI) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Thank you for viewing the detailed overview of Rockwell Medical's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.
Mark Strobeck | director, officer: President and CEO | 460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087 |
Mark H Ravich | other: See Footnote 1 | |
Jesse Neri | officer: SVP, FINANCE | 851 DUPORTAIL ROAD, SECOND FLOOR, CHESTERBROOK PA 19087 |
Joan Lau | director | C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830 |
Russell Skibsted | officer: See Remarks | 15 TRANQUILITY PLACE, LADERA RANCH CA 92694 |
Megan C. Timmins | officer: SVP, General Counsel | 600 LEE ROAD, SUITE 100, WAYNE PA 19087 |
Allen Nissenson | director | 601 HAWAII ST., EL SEGUNDO CA 90245 |
Robert S Radie | director | 101 LINDENWOOD DRIVE, SUITE 225, MALVERN PA 19355 |
Andrea Heslin Smiley | director | 600 LEE ROAD, SUITE 100, WAYNE PA 19087 |
David S. Richmond | 10 percent owner, other: See Footnote 1 | 3568 WILDWOOD AVENUE, JACKSON MI 49202 |
Russell H Ellison | director | 270 RIVERSIDE DR., APT. 12D, NEW YORK NY 10025 |
Marc L Hoffman | officer: Chief Medical Officer | 30142 WIXOM ROAD, WIXOM MI 48393 |
John Peter Mclaughlin | director | C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BOULEVARD, INCLINE VILLAGE NV 89451 |
Richmond Brothers, Inc. | 10 percent owner, other: See Footnote 1 | 7415 FOXWORTH COURT, JACKSON MI 49201 |
Stuart M Paul | director, officer: Chief Executive Officer | HOME DIAGNOSTICS, INC., 2400 NW 55TH COURT, FORT LAUDERDALE FL 33309 |
From GuruFocus
By GuruFocus Research • 05-15-2024
By GuruFocus News • 11-15-2024
By GuruFocus News • 11-11-2024
By Business Wire • 11-08-2024
By Business Wire • 12-05-2024
By Business Wire • 05-30-2024
By Business Wire • 08-07-2024
By Business Wire • 09-18-2024
By GuruFocus Research • 09-09-2024
By GuruFocus News • 11-13-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.